# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, Regulation 216: Amendment of Schedule 30 (particulars for advertisements to persons qualified to prescribe or supply)

Extent: E+W+S+N.I.

In Schedule 30—
(a) in paragraphs 1, 2 and 6, for “marketing authorisation,” substitute “UK marketing authorisation, EU marketing authorisation”;
(b) after paragraph 2 insert—
“2A. In relation to an advertisement in Great Britain (other than an advertisement falling within the exception in regulation 296) where the medicinal product concerned is authorised under a UKMA(GB), a statement that the product concerned is authorised under a UKMA(GB).”.

---
Source: https://www.legislation.gov.uk/uksi/2019/775/regulation/216 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2019/regulation-216
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.